Estimation of Immunoglobulins and complements and Using Enzyme linked Immuno sorbant Assay in Identification of Vulvovaginal candidiasis

This study was conducted to determine the Immuno – globulins and complements quantitatively. The result revealed that the concentration of Immunoglobulin M(IgM) was increased significantly in patient group comparing with control group . The concentration of complement protein C4 was increased signif...

Full description

Bibliographic Details
Published in:	مجلة بغداد للعلوم
Main Author:	Baghdad Science Journal
Format:	Article
Language:	English
Published:	University of Baghdad, College of Science for Women 2009-09-01
Subjects:	"Vulvovaginal Candidiasis, ELISA, Candida spp"
Online Access:	http://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/999

Similar Items

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Identification of Candida species Isolated From Vulvovaginal Candidiasis Patients by Chromgen agar and PCR-RFLP Method
by: Baghdad Science Journal
Published: (2016-06-01)

Effect of Some predisposing factors on Vulvovaginal Candidiasis
by: Baghdad Science Journal
Published: (2010-09-01)

Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)

Population level of main microbiota and yeast-like Candida fungi in women with vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-06-01)

Modern concepts of etiopathogenesis and approaches to the treatment of recurrent vulvovaginal candidiasis
by: Margarita R. Rakhmatulina
Published: (2023-10-01)

The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis
by: Li L, et al.
Published: (2024-10-01)

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
by: Jian Miao, et al.
Published: (2023-04-01)

Carbohydrate Derived Fulvic Acid for the Treatment of Vulvovaginal Candidiasis
by: Stewart Clark, et al.
Published: (2024-12-01)

The Burden of Vulvovaginal Candidiasis Among Women in Developing Countries: A Systematic Review
by: Sule, H. , Kumurya, A. S. and Ahmad I. A.
Published: (2019-03-01)

Differential PCR diagnosis of bacterial vaginosis, aerobic vaginitis and vulvovaginal candidiasis
by: T. I. Makhova, et al.
Published: (2022-06-01)

Natamycin in the treatment of chronic recurrent vulvovaginal candidiasis associated with intestinal candidiasis
by: I. O. Malova, et al.
Published: (2018-09-01)

Vulvovaginal Candidiasis Among Women with Bacterial Vaginosis Attending Aminu Kano Teaching Hospital, Nigeria
by: Sule, H.*, Kumurya, A.S., Nasir, A.
Published: (2018-03-01)

Treatment of vulvovaginal candidiasis in preparation programs for in vitro fertilization
by: A. Yu. Romanov, et al.
Published: (2021-10-01)

Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates
by: Sayanika Devi Waikhom, et al.
Published: (2020-05-01)

Genetic susceptibility to recurrent vulvovaginal candidiasis in an African population from Nairobi, Kenya
by: Gloria S. Omosa-Manyonyi, et al.
Published: (2025-04-01)

Differentiated approach to the treatment of various forms of vulvovaginal candidiasis
by: T Yu Pestrikova, et al.
Published: (2014-06-01)

The Prevalence of Non-albicans Candida and Candida Mixed-species in Vulvovaginal Candidiasis in Northeast Iran
by: Batoul Jannati, et al.
Published: (2024-03-01)

In Vitro Evaluation of Corn Silk Extract as a Potential Alternative Therapy for Vulvovaginal Candidiasis
by: Liberty P., et al.
Published: (2023-12-01)

Efficacy and safety of ibrexafungerp in the treatment of vulvovaginal candidiasis: A meta-analysis of randomized controlled trials
by: Rong He, et al.
Published: (2024-04-01)

Clinical case: patient treated for vulvovaginal candidiasis
by: Tatyana Yu. Pestrikova
Published: (2021-02-01)

Advanced therapy for eternal vulvovaginal candidiasis recurrences
by: I. A. Kulikov
Published: (2020-10-01)

Comparative Fungicidal Activities of N-Chlorotaurine and Conventional Antiseptics against <i>Candida</i> spp. Isolated from Vulvovaginal Candidiasis
by: Mayram Hacioglu, et al.
Published: (2022-06-01)

Prevalence of Closely Related Candida albicans Species among Patients with Vulvovaginal Candidiasis in Southern Poland Based on the hwp1 Gene Amplification
by: KLESIEWICZ KAROLINA, et al.
Published: (2023-03-01)

Vulvovaginal Candidiasis and its Related Factors in Diabetic Women
by: Ozra Tabatabaei Malazy, et al.
Published: (2007-12-01)

Characterization of ERG11 Gene in Drug-Resistant Candida Albicans Isolated from Iranian Cases of Recurrent Vulvovaginal Candidiasis
by: Kambiz Diba, et al.
Published: (2020-06-01)

Clinical, microbiological and therapeutic aspects of vulvovaginal candidiasis and recurrent vulvovaginal candidiasis: importance of regional surveys
by: Márcio Tavares Rodrigues, et al.
Published: (2010-02-01)

In vitro photodynamic therapy of Candida albicans, the cause of vulvovaginal candidiasis, is enhanced by Bacillus and Enterococcus probiotics
by: Zeinab Ghanbari, et al.
Published: (2025-02-01)

Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
by: Humberto Fabio Boatto, et al.
Published: (2016-06-01)

Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis
by: Mei Gao, et al.
Published: (2016-11-01)

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
by: V. N. Serov, et al.
Published: (2016-12-01)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
by: Narges Aslani, et al.
Published: (2021-12-01)

Vaginal Candidiasis among Pregnant Women in Ebonyi State, South East Nigeria.
by: Chito Clare Ekwealor, et al.
Published: (2023-09-01)

Epidemiological profile and fluconazole susceptibility of patients with vulvovaginal candidiasis in northeast Iran
by: Raheleh Alhashem, et al.
Published: (2024-01-01)

Use of antifungals in the treatment of vulvovaginal candidiasis: an integrative review
by: Kellyane Folha Gois Moreira, et al.
Published: (2023-12-01)

Zinc Plasma Levels in Recurrent Vulvovaginal Candidiasis Patients
by: Deryne Anggia Paramita, et al.
Published: (2017-04-01)

The Validity of Point-of-Care Test (POCT) Lateral Flow Immunochromatographic Assay (LFIA) Candida albicans for the Diagnosis of Vulvovaginal Candidiasis
by: Monika Puspitasari, et al.
Published: (2024-07-01)

Design and evaluation of antifungal vaginal suppository using coconut oil as base for vulvovaginal candidiasis
by: Ayomide D. Mustapha, et al.
Published: (2023-09-01)

Modern opportunities for the diagnosis and treatment of vulvovaginal candidiasis (in aid of a practitioner)
by: E. R. Dovletkhanova, et al.
Published: (2019-10-01)